Vitamin E treatment in tardive dystonia

Pinhas N. Dannon; Leon Grunhaus; Iulian Iancu; Alon Braf; Elic Lepkifker

doi:10.1097/00002826-199710000-00007

Vitamin E treatment in tardive dystonia

Pinhas N. Dannon^*, Leon Grunhaus, Iulian Iancu, Alon Braf, Elic Lepkifker

^*Corresponding author for this work

Sheba Medical Center at Tel Hashomer

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Tardive dystonia is a disorder characterized by abnormally sustained posturing associated with the use of dopamine-receptor blocking agents such as antipsychotic drugs. However, the structural pathologic and pathophysiologic features of this disorder are unknown, and no consistently effective pharmacologic treatment is available. Patients with tardive dystonia mostly are young men. We present the case of one young man with tardive dystonia secondary to neuroleptic treatment, whose condition substantially improved with treatment by 1200 mg/d (IU) of vitamin E.

Original language	English
Pages (from-to)	434-437
Number of pages	4
Journal	Clinical Neuropharmacology
Volume	20
Issue number	5
DOIs	https://doi.org/10.1097/00002826-199710000-00007
State	Published - 1997
Externally published	Yes

Keywords

Abnormal involuntary movement scale (AIMS)
Tardive dystonia
Vitamin E

Access to Document

10.1097/00002826-199710000-00007

Cite this

@article{c8985679da544d5f8ac5b725c2baf7ec,

title = "Vitamin E treatment in tardive dystonia",

abstract = "Tardive dystonia is a disorder characterized by abnormally sustained posturing associated with the use of dopamine-receptor blocking agents such as antipsychotic drugs. However, the structural pathologic and pathophysiologic features of this disorder are unknown, and no consistently effective pharmacologic treatment is available. Patients with tardive dystonia mostly are young men. We present the case of one young man with tardive dystonia secondary to neuroleptic treatment, whose condition substantially improved with treatment by 1200 mg/d (IU) of vitamin E.",

keywords = "Abnormal involuntary movement scale (AIMS), Tardive dystonia, Vitamin E",

author = "Dannon, \{Pinhas N.\} and Leon Grunhaus and Iulian Iancu and Alon Braf and Elic Lepkifker",

year = "1997",

doi = "10.1097/00002826-199710000-00007",

language = "אנגלית",

volume = "20",

pages = "434--437",

journal = "Clinical Neuropharmacology",

issn = "0362-5664",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Vitamin E treatment in tardive dystonia

AU - Dannon, Pinhas N.

AU - Grunhaus, Leon

AU - Iancu, Iulian

AU - Braf, Alon

AU - Lepkifker, Elic

PY - 1997

Y1 - 1997

N2 - Tardive dystonia is a disorder characterized by abnormally sustained posturing associated with the use of dopamine-receptor blocking agents such as antipsychotic drugs. However, the structural pathologic and pathophysiologic features of this disorder are unknown, and no consistently effective pharmacologic treatment is available. Patients with tardive dystonia mostly are young men. We present the case of one young man with tardive dystonia secondary to neuroleptic treatment, whose condition substantially improved with treatment by 1200 mg/d (IU) of vitamin E.

AB - Tardive dystonia is a disorder characterized by abnormally sustained posturing associated with the use of dopamine-receptor blocking agents such as antipsychotic drugs. However, the structural pathologic and pathophysiologic features of this disorder are unknown, and no consistently effective pharmacologic treatment is available. Patients with tardive dystonia mostly are young men. We present the case of one young man with tardive dystonia secondary to neuroleptic treatment, whose condition substantially improved with treatment by 1200 mg/d (IU) of vitamin E.

KW - Abnormal involuntary movement scale (AIMS)

KW - Tardive dystonia

KW - Vitamin E

UR - http://www.scopus.com/inward/record.url?scp=0030846227&partnerID=8YFLogxK

U2 - 10.1097/00002826-199710000-00007

DO - 10.1097/00002826-199710000-00007

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 9331519

AN - SCOPUS:0030846227

SN - 0362-5664

VL - 20

SP - 434

EP - 437

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

IS - 5

ER -

Vitamin E treatment in tardive dystonia

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this